CWNewsBreaks Archive - Page 10 of 20

ThursdayOct 28, 2021 11:35 am

ChineseNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) in a League of Its Own

Infobird (NASDAQ: IFBD) is a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company that is constantly pushing the envelope with innovation and technology, further reinforcing its title as a company of firsts and also as the undisputed industry leader. IFBD has made a name for itself by leveraging proprietary next-generation technology, a product of years of research and development. “This has allowed it to stamp its position as a leader in the software-as-a-service (‘SaaS’) industry, particularly in the Chinese market,” reads a recent article. “Infobird is one of the very few companies in China to have built, from scratch, a customer…

TuesdayOct 26, 2021 9:55 am

ChineseNewsBreaks – FingerMotion Inc. (FNGR) Subsidiary Trademarks Two New Brands Targeting Innovative Device Protection

FingerMotion (OTCQX: FNGR), a mobile data and services company, through its subsidiary Shanghai JiuGe Information Technology Co. Ltd., has trademarked two new brands. The two trademarked brands — Ji Shi Fu and Baowo — are designed to support the company’s planned underwriting of an innovative device protection program for telecom customers in China. According to the company, this maintenance program could include up to hundreds of stores in more than 10 provinces; potential products and services include broken mobile phone screens, accidental damage repairs and compensation, older device trade-ins and other services. The program could also spark growth, including adding new users…

FridayOct 22, 2021 12:15 pm

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd.’s (NASDAQ: ANPC) Unique Platform Offering Comprehensive Blood Test Data, New Approach to Disease Screening

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, has developed the Cancer Differentiation Analysis (“CDA”) technology — a proprietary approach to detect cancerous and pre-cancerous diseases. “CDA uses the blood’s natural biophysical properties to identify cancerous environments before tumors even form. The CDA platform, in which technology is combined with protein-based biomarker tests to obtain even more comprehensive information, can be used to obtain more comprehensive data and information,” explains a recent article. “Unlike most liquid-based cancer screening and detection methods, the CDA platform from AnPac Bio focuses on assessing the existing protein-based…

MondayOct 18, 2021 12:03 pm

ChineseNewsBreaks – FingerMotion Inc. (FNGR) Providing Corporate Clients with Standout Technology

FingerMotion (OTCQX: FNGR), a big data communications technology innovator, is focusing its new big data platform, Sapientus, on China’s insurance market. Speaking during an August corporate update conference call, FingerMotion CEO Martin Shen acknowledged that the company has also considered eventually focusing its big data platform on other industries beyond insurance and in markets beyond China’s borders. However, Shen indicated that the company will stay focused on its immediate purpose before expanding its reach. “FingerMotion launched its Big Data Insights division with its flagship database IP Sapientus last year and attracted global insurance behemoth Pacific Life Re-insurance as a client…

FridayOct 15, 2021 9:46 am

ChineseNewsBreaks – FingerMotion Inc. (FNGR) Releases Financial Report for Q2 2022

FingerMotion (OTCQX: FNGR), a mobile data and services company, has reported its financial numbers for quarter two, the period ending Aug. 31, 2021. Company officials noted that the quarter was a transition to greater profitability as more of its initiatives began contributing to the gross margin; in addition, FNGR hit a milestone of more than $5 million in shareholders’ equity. Other highlights of the report included quarterly revenue of $5.39 million stemming from the company’s SMS & MMS, Telecommunications Products & Services businesses, and Big Data. SMS & MMS business revenue for the quarter grew 25%, or $0.73 million, compared…

MondayOct 11, 2021 1:41 pm

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Stands Distinct in World of Cancer Prevention, Treatment

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a proven early thought leader and developer of multi-cancer (also called pan-cancer) ideas and technology. “AnPac Bio is one of the first companies in the world to produce major theories and methods of multi-level, multi-parameter and multi-cancer screening. The innovative technology has opened up a new field in early cancer screening that is based on a biophysical property and has achieved significant results,” reads a recent article. AnPac Bio has one of the largest sample libraries in the world, with more than 220,000 samples…

FridayOct 08, 2021 11:52 am

ChineseNewsBreaks – FingerMotion Inc. (FNGR) Poised as Ideal Partner in Post-Pandemic Insurance Space in China

FingerMotion (OTCQX: FNGR) is a technology company with core competencies in SMS/MMS services, mobile payment and recharge solutions, and big data insights. Following revelations that the pandemic posed a significant challenge to the adaptability and resilience of insurance companies and their management teams, Deloitte China proposed that insurers apply big data to facilitate product differentiation and build digital operational capabilities to ensure longevity post-pandemic. In this regard, FingerMotion appears poised as an ideal partner for insurers looking to implement Deloitte China’s proposals. Through its big data insights division (“Sapientus”), which provides behavioral analytics sourced from publicly available data, FNGR is…

WednesdaySep 29, 2021 2:35 pm

ChineseNewsBreaks – FingerMotion Inc. (FNGR) Leveraging Sapientus(TM) to Provide Clients with Big-Data Insights

FingerMotion (OTCQX: FNGR) is providing its clients with market insights as a growing number of Chinese consumers adopt online insurance products. According to the Google translation of a news release issued by Gold Investment Network, China’s online insurance premiums surpassed 290 billion yuan (US$44.8 million) last year (https://ibn.fm/7g2lO). The popularity of online premiums fueled a rapid surge in new economic activity within the country, which continues on an upward path as businesses turn to big data, cloud computing, artificial intelligence (“AI”), and other value-added technology to accelerate revenues. “FingerMotion has seen its revenues grow in consecutive reporting quarters during the…

WednesdaySep 29, 2021 1:48 pm

ChineseNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) Delivering Cutting-Edge Solutions for Retail and Consumer Products Industry

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, recently entered into a service contract with a subsidiary of a global leading retail brand (https://ibn.fm/7cclL). The Fortune 500 retail and consumer product company, with operations in over 80 countries worldwide, hopes to capitalize on Infobird’s intelligent quality inspection in a bid to significantly improve its customer service system. “Infobird is a software-as-a-service (‘SaaS’) provider, offering artificial intelligence (‘AI’)-powered customer engagement solutions for the Chinese market. Since it was founded in October 2001, the company has always sought to bring value to its clients with solutions to increase revenue,…

FridaySep 24, 2021 1:36 pm

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd.’s (NASDAQ: ANPC) CDA Technology Detects Risk of Over 25 Different Cancer Types

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a recognized innovator and leader in the field of early cancer screening and detection. Its core product and proven revenue generator, the pioneering Cancer Differentiation Analysis (“CDA”) platform, offers novel capabilities by looking for signals to help it assess the risk of cancer occurring before a tumor has developed. This approach is unlike the blood sample-based cancer screenings, which generally target protein-based biomarkers, genomic signals, such as circulating tumor DNA (“ct-DNA”), circulating in the bloodstream to determine if a cancer exists and is spreading.…

ChineseWire provides insights and opportunities in Chinese companies.

Contact us: (512) 354-7000

ChineseNewsBreaks